{"database": "lobbying", "table": "lobbying_activities", "rows": [[1261074, "d15a28bd-b85a-4687-9020-4ab15ad7971f", "Q2", "TURNER & GOSS LLP", 316310, "CYSTIC FIBROSIS FOUNDATION", 2012, "second_quarter", "MED", "Food and Drug Administration Safety and Innovation Act, including provisions of the Expanding and Promoting Exertise in Review of Rare Treatments Act of 2012 (S. 2281/HR 4156) as incorporated in the Act", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2012-07-12T12:35:32.277000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1261074"], "units": {}, "query_ms": 0.6180111085996032, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}